4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001415889-25-009937
CEO gave up 3,042 shares (to pay taxes)
- CEO acquired 9,467 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Walker Neal CEO | 2025-04-01 | Option exercise | +9,467 | 1,476,374 | D | ||
| Walker Neal CEO | 2025-04-01 | Shares withheld for taxes | −3,042 | $1.48 | $4,502 | 1,473,332 | D |
| Derivatives | |||||||
| Walker Neal CEO | 2025-04-01 | Option exercise · Restricted Stock Units | −9,467 | 9,467 | D | ||
Loading xslF345X05/form4-04032025_040410.xml…